Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single high-dose vitamin D3 injection before surgery in intertrochanteric hip fracture and 6‑month mortality
IRCT20180729040636N2Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Nov 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of vitamin d in intertrochanteric fracture, sponsored by Isfahan University of Medical Sciences. Primary endpoint: 6‑month all-cause mortality. Started Nov 2019; status: completed.
02
Drugs
vitamin d
03
Conditions
intertrochanteric fracture
Beyond the preview
Go deeper on IRCT20180729040636N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180729040636N2.